Adaptive Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
CEOChad Robins
CEOChad Robins
Employees619
Employees619
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2009
Founded2009
Employees619
Employees619
ADPT Key Statistics
Market cap1.79B
Market cap1.79B
Price-Earnings ratio-12.32
Price-Earnings ratio-12.32
Dividend yield—
Dividend yield—
Average volume2.74M
Average volume2.74M
High today$12.05
High today$12.05
Low today$11.67
Low today$11.67
Open price$12.05
Open price$12.05
Volume1.63M
Volume1.63M
52 Week high$12.43
52 Week high$12.43
52 Week low$3.85
52 Week low$3.85
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.